Monoclonal Antibodies

Houston Officials Dispute Serial Killer Rumors Amid Bayou Body Recoveries

Rumors of a serial killer operating in Houston’s waterways are being refuted by the Harris County District Attorney, Sean Teare, following the recent discovery of three bodies. The Houston Police Department confirmed the recovery of bodies from various bayous in late December. Despite online speculation, Teare stated there is no evidence to suggest a serial killer is responsible, attributing many of the deaths to factors like the city’s homeless population and substance abuse issues. The mayor’s office also extended condolences, emphasizing the city’s vast network of waterways and the ongoing investigation into each case, with autopsy results still pending.

Read More

33 Bayou Deaths in Houston This Year Spark Concern, Investigations Underway

On Monday, Houston police recovered two bodies from local bayous, bringing the year’s total to 33 bayou-related deaths, nearly matching last year’s total. One body was found in Buffalo Bayou and the other near Brays Bayou, with the latter significantly decomposed. The Harris County medical examiner’s office will conduct autopsies to determine the identities and causes of death for both individuals. These discoveries follow increased attention on bayou-related deaths, which have seen over 200 bodies found in the past nine years.

Read More

New Asthma Treatment: Hype vs. Reality—Expensive Injections, Limited Access

Research from King’s College London reveals benralizumab, an injectable drug already used for severe cases, as the first new asthma attack treatment in 50 years. Targeting eosinophils, a type of white blood cell contributing to lung inflammation, the therapy significantly reduced treatment failure rates compared to steroids (45% vs. 74%) in a 158-person trial. This new approach offers improved symptoms, quality of life, and reduced hospitalizations, potentially impacting the two million asthma attacks annually in the UK. While further large-scale trials are needed, the findings suggest a potential “game-changer” in asthma and COPD treatment.

Read More